11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

VTS Critical Concept: Endocrine hyper- and hypo-metabolic emergencies present dramatic physiological extremes. Feline thyroid storm represents an explosive surge in thyroid hormone activity combined with massive sympathetic $\beta$-adrenergic hypersensitivity, where aggressive IV fluid therapy can precipitate fatal pulmonary edema. In contrast, severe hypoglycemia deprives the central nervous system of its primary metabolic substrate, demanding rapid hypertonic dextrose dilution, constant rate infusion to prevent rebound hypoglycemia, and adjunctive Glucagon CRI for refractory neuroendocrine crises.

---

1. Pathophysiology of Feline Thyroid Storm & Thyrotoxicosis

Thyroid Storm is an acute, life-threatening decompensation of thyrotoxicosis encountered in geriatric cats with underlying functional thyroid adenomatous hyperplasia or thyroid carcinoma.

[ Acute Surge of Free T3 / T4 + Massive Adrenergic Receptor Hypersensitization ]
                                     │
         ┌───────────────────────────┴───────────────────────────┐
         ▼                                                       ▼
[ Extreme Hypermetabolism & Thermogenesis ]             [ Cardiovascular Beta-Receptor Stimulation ]
• Uncoupling of oxidative phosphorylation               • Upregulation of β1 & β2 adrenergic receptors
• Massive cellular oxygen consumption                   • Extreme tachycardia (HR > 240-260 bpm)
• Malignant hyperthermia (> 105.8°F / 41°C)             • Malignant tachyarrhythmias (VPCs, V-Tach, A-Fib)
• Profound muscle catabolism & cachexia                 • Severe systemic hypertension (SBP > 180-220 mmHg)
         │                                                       │
         └───────────────────────────┬───────────────────────────┘
                                     ▼
         [ High-Output Heart Failure ──► Cardiogenic Pulmonary Edema / Pleural Effusion ]
         [ Acute Retinal Detachment ──► Hyphema / Sudden Blindness ──► Delirium / Death ]

Cellular Mechanisms of Thyroid Hormone Excess

1. Upregulation of Adrenergic Receptors: Thyroid hormones ($T_3$ and $T_4$) dramatically increase the density and affinity of $\beta_1$- and $\beta_2$-adrenergic receptors on myocardial and vascular smooth muscle cells, creating an extreme hypersensitivity to normal or elevated levels of circulating catecholamines.
2. Uncoupling of Oxidative Phosphorylation: Excess $T_3$ stimulates mitochondrial inner membrane uncoupling proteins (UCPs) and upregulates cellular $\text{Na}^+/\text{K}^+$-ATPase synthesis, converting cellular energy directly into massive amounts of thermal energy (malignant hyperthermia).
3. Thyrotoxic Cardiomyopathy: Chronic thyrotoxicosis induces concentric left ventricular hypertrophy (hypertrophic cardiomyopathy phenotype) and high-output circulatory failure. When thyroid storm occurs, extreme tachycardia shortens diastolic filling time, causing acute congestive heart failure (cardiogenic pulmonary edema and pleural effusion).

Precipitating Triggers

Thyroid storm rarely occurs spontaneously; it is typically precipitated by an acute stressor in a chronically hyperthyroid cat:

• Severe non-thyroidal systemic illness (e.g., acute pancreatitis, diabetic ketoacidosis, systemic infection, acute kidney injury).
• Vigorous palpation of the cervical thyroid region (rupture/leakage of thyroid follicles).
• Radioiodine ($^{131}\text{I}$) therapy or thyroidectomy surgery.
• Abrupt withdrawal or discontinuation of chronic methimazole therapy.
• General anesthesia or severe environmental stress.

Clinical Presentation: Classical vs. Apathetic Thyrotoxicosis

• Classical Thyroid Storm Signs: Extreme malignant hyperthermia ($>105.0-106.5^\circ\text{F}\ /\ >40.5-41.4^\circ\text{C}$), severe sinus tachycardia ($>240-280\text{ bpm}$), gallop rhythms, systolic murmurs, ventricular premature complexes (VPCs), paroxysmal ventricular tachycardia, atrial fibrillation, tachypnea, open-mouth panting, severe systemic hypertension (systolic BP $>180-220\text{ mmHg}$), acute retinal hemorrhage/detachment (sudden blindness), agitation, pacing, delirium, and sudden collapse.
• Apathetic Thyrotoxicosis (10-15% of cases): An atypical presentation characterized by profound depression, severe lethargy, complete anorexia, marked muscle wasting, weakness, ventral neck flexion (secondary to hypokalemic polymyopathy), and paradoxically normal or subnormal body temperature (hypothermia).

---

2. Emergency Management of Thyroid Storm

Resuscitation of thyroid storm requires a delicate balance between adrenergic blockade, anti-thyroid pharmacotherapy, cooling, and extreme fluid restraint.

---

3. Pathophysiology of Severe Hypoglycemia & Neuroglycopenia

Severe hypoglycemia is defined as blood glucose $<50-60\text{ mg/dL}$ ($<2.8-3.3\text{ mmol/L}$). The central nervous system is exceptionally vulnerable to glucose deprivation because the brain lacks endogenous glycogen stores and depends entirely on continuous glucose delivery across the blood-brain barrier via non-insulin-dependent glucose transporters (GLUT-1 on endothelial cells and GLUT-3 on neurons).

[ Blood Glucose < 50-60 mg/dL (2.8-3.3 mmol/L) ]
                       │
        ┌──────────────┴──────────────┐
        ▼                             ▼
[ Autonomic Counter-Regulatory Surge ] [ Neuroglycopenia (Neuronal Fuel Starvation) ]
• Epinephrine & Norepinephrine release • Brain glucose extraction failure
• Glucagon & Cortisol elevation        • Impaired neuronal ATP generation
• Tachycardia, anxiety, restlessness   • Failure of cellular Na+/K+-ATPase pumps
• Peripheral vasoconstriction & hunger • Intracellular calcium influx & glutamate excitotoxicity
        │                             │
        └──────────────┬──────────────┘
                       ▼
[ Disorientation ──► Ataxia ──► Cortical Blindness ──► Status Epilepticus ──► Coma / Brain Death ]

Clinical Progression of Neuroglycopenia

• Early Autonomic Phase ($50-60\text{ mg/dL}$): Restlessness, pacing, intense hunger, trembling, sinus tachycardia, and dilated pupils.
• Moderate Neuroglycopenic Phase ($35-50\text{ mg/dL}$): Mental confusion, glassy-eyed stare, profound weakness, generalized ataxia, conscious proprioceptive deficits, and transient cortical blindness (loss of menace with intact pupillary light reflexes).
• Severe Neuroglycopenic Crisis ($<30-35\text{ mg/dL}$): Focal facial myoclonus (lip-smacking, twitching), generalized tonic-clonic seizures, status epilepticus, stupor, coma, decerebrate posturing, and irreversible ischemic neuronal necrosis.

---

4. Critical Differential Diagnoses for Hypoglycemia

5. Emergency Hypoglycemia Resuscitation Protocols

Step 1: Emergency IV Dextrose Bolus

• Dosage: $50%\text{ Dextrose (0.5 g/mL)}$ at $0.5-1.0\text{ mL/kg}$ ($0.25-0.5\text{ g/kg IV}$).
• MANDATORY DILUTION PROTOCOL: Never administer undiluted $50%$ dextrose through a peripheral IV catheter. Undiluted $50%$ dextrose has an osmolality of approximately $2,525\text{ mOsm/L}$ ($>8\times$ normal serum osmolality). Rapid peripheral injection causes severe chemical thrombophlebitis, endothelial necrosis, and severe tissue sloughing if extravasation occurs. Always dilute $1:1$ with sterile $0.9%\text{ saline}$ or sterile water to create a $25%$ solution, or $1:2$ to create a $16.7%$ solution, and infuse slowly over $5-10\text{ minutes}$.
• Oral Transmucosal Dextrose / Karo Syrup: If IV access cannot be immediately established in an actively seizing patient at home or during triage, apply a small amount of concentrated corn syrup (Karo syrup) or $50%$ dextrose directly to the oral buccal mucosa. Caution: Never administer large liquid volumes into the pharynx of an unconscious or seizing animal due to the extreme risk of fatal pulmonary aspiration.

Step 2: Continuous Dextrose Maintenance (Preventing Rebound Hypoglycemia)

• An intravenous hypertonic dextrose bolus stimulates a secondary compensatory wave of endogenous insulin release from the pancreas. In patients with an insulinoma or xylitol toxicosis, this triggers massive rebound reactive hypoglycemia, driving blood glucose even lower than initial presentation.
• Protocol: Immediately follow the initial dextrose bolus with a constant rate infusion of $2.5%$ to $5.0%$ Dextrose in balanced isotonic crystalloids.
  • To make $2.5%$ Dextrose: Add $50\text{ mL}$ of $50%$ dextrose to $950\text{ mL}$ of fluids.
  • To make $5.0%$ Dextrose: Add $100\text{ mL}$ of $50%$ dextrose to $900\text{ mL}$ of fluids.

Step 3: Refractory Hypoglycemia & Glucagon CRI

When patients with functional insulinomas, massive xylitol ingestions, or severe long-acting insulin overdoses fail to maintain euglycemia ($>70-80\text{ mg/dL}$) despite $5-10%$ dextrose infusions:

1. Glucagon Constant Rate Infusion (CRI):
   • Mechanism: Glucagon binds to specific G-protein coupled receptors on hepatocytes, activating adenylate cyclase to generate cyclic AMP (cAMP). This directly stimulates hepatic glycogenolysis and gluconeogenesis while inhibiting glycolysis, completely bypassing insulin receptor blockade.
   • Dosing: Administer an IV loading dose of $5\text{ ng/kg}$, followed by a CRI starting at $5-10\text{ ng/kg/min}$, titrated upward to $15-20\text{ ng/kg/min}$ based on serial blood glucose monitoring.
2. Glucocorticoid Therapy: Administer Dexamethasone Sodium Phosphate ($0.1-0.2\text{ mg/kg IV q12-24h}$). Glucocorticoids induce hepatic gluconeogenic enzymes (phosphoenolpyruvate carboxykinase) and inhibit peripheral GLUT-4 translocation in skeletal muscle and adipose tissue, promoting peripheral insulin resistance.
3. Anticonvulsant Therapy: If seizures persist despite restoring blood glucose $>80\text{ mg/dL}$, administer Midazolam ($0.2-0.5\text{ mg/kg IV}$) or Levetiracetam ($60\text{ mg/kg IV}$) to control secondary neuroglycopenic seizure foci and prevent ongoing cerebral metabolic exhaustion.